← Leaderboards
Jason George
Rice University
$891,804
Attributed
$891,804
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $360K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$891,804 · 2
By mechanism
R35$718,079 · 1
F30$173,725 · 1
Top collaborators
No co-investigators on record.
Most similar at Rice University
Same institution · by research overlap
- Natasha Kirienko$4,948,787
- Christopher Paul Fagundes$11,283,200
- Kyriacos A Athanasiou$18,036,454
- Jeffrey Dale Hartgerink$2,762,636
- Fred Kurtis Kasper$1,413,686
Others in their field
Other Emerging Leaders on “Immune”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmuneSamplingT-LymphocyteImmune SystemAntigensMalignant NeoplasmsLeukemiaEvolutionDrug ResistanceExome SequencingAffectAcute Myelocytic LeukemiaAftercareEpitopesAutoantigensArchitectureDetectionCancer SurvivalCd8b1 GeneCd8-Positive T-LymphocytesCellsChemotherapyClinically TranslatableCancer Patient
Grant awards (6)
Quantifying phenotypic adaptation of biological systems in dynamic environments$360,016
R35 · FY2025 · GM · contact PI
Quantifying phenotypic adaptation of biological systems in dynamic environments$358,063
R35 · FY2024 · GM · contact PI
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy$29,517
F30 · FY2020 · CA · contact PI
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy$45,640
F30 · FY2019 · CA · contact PI
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy$49,524
F30 · FY2018 · CA · contact PI
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy$49,044
F30 · FY2017 · CA · contact PI